Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
出版年份 2022 全文链接
标题
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
作者
关键词
-
出版物
Nature Reviews Neurology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-19
DOI
10.1038/s41582-022-00665-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults
- (2022) Pierre‐François Meyer et al. ANNALS OF NEUROLOGY
- The accuracy and robustness of plasma biomarker models for amyloid PET positivity
- (2022) Andréa L. Benedet et al. Alzheimers Research & Therapy
- Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET
- (2022) Cécile Tissot et al. EBioMedicine
- Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
- (2022) Nicholas J. Ashton et al. EBioMedicine
- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
- (2022) Emma Nichols et al. Lancet Public Health
- Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
- (2022) Denis S. Smirnov et al. ACTA NEUROPATHOLOGICA
- CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
- (2022) Alexis Moscoso et al. Alzheimers & Dementia
- Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
- (2022) Suzanne E. Schindler et al. NEUROLOGY
- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
- (2021) Joel Simrén et al. Alzheimers & Dementia
- Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative
- (2021) Anna Zettergren et al. Alzheimers Research & Therapy
- The Future Is P-Tau—Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests
- (2021) Emily A. Largent et al. JAMA Neurology
- Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
- (2021) Alexis Moscoso et al. JAMA Neurology
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
- (2021) Adam M. Brickman et al. Alzheimers & Dementia
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
- (2021) N. J. Ashton et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
- (2021) A. Leuzy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
- (2021) Henrik Zetterberg et al. Molecular Neurodegeneration
- Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
- (2021) Andrew G. B. Thompson et al. MOLECULAR PSYCHIATRY
- Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease
- (2021) Joyce R. Chong et al. Alzheimers & Dementia
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
- (2021) Niklas Mattsson‐Carlgren et al. EMBO Molecular Medicine
- Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
- (2021) Christopher Clark et al. Alzheimers Research & Therapy
- Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s disease
- (2021) Cécile Tissot et al. Alzheimers Research & Therapy
- Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
- (2021) Pratishtha Chatterjee et al. Alzheimers & Dementia
- Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
- (2021) Daniel Alcolea et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
- (2021) Elisabeth H Thijssen et al. LANCET NEUROLOGY
- Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
- (2021) Sebastian Palmqvist et al. NATURE MEDICINE
- Can we learn lessons from the FDA’s approval of aducanumab?
- (2021) Kathy Y. Liu et al. Nature Reviews Neurology
- Developing the ATX(N) classification for use across the Alzheimer disease continuum
- (2021) Harald Hampel et al. Nature Reviews Neurology
- Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
- (2021) Michel J. Grothe et al. NEUROLOGY
- Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
- (2021) Alberto Lleó et al. Nature Communications
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- Plasma Biomarkers of Tau and Neurodegeneration During Major Cardiac and Noncardiac Surgery
- (2021) Igor Feinstein et al. JAMA Neurology
- Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
- (2021) Alexandre Bejanin et al. JAMA Neurology
- Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
- (2021) Michelle M. Mielke et al. JAMA Neurology
- MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
- (2021) Chihiro Sato et al. Annals of Clinical and Translational Neurology
- CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles
- (2021) Stephan A. Kaeser et al. ACTA NEUROPATHOLOGICA
- TRAILBLAZER‐ALZ Study: Dynamics of amyloid reduction after donanemab treatment
- (2021) Sergey Shcherbinin et al. Alzheimers & Dementia
- Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
- (2021) Inge M. W. Verberk et al. Alzheimers & Dementia
- P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
- (2021) Juan Lantero‐Rodriguez et al. EMBO Molecular Medicine
- Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
- (2021) Sherif Bayoumy et al. Alzheimers Research & Therapy
- Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- (2021) Antoine Leuzy et al. JAMA Neurology
- N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases
- (2021) Anniina Snellman et al. BRAIN
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Psychological reactions to predictive genetic testing for Huntington’s disease: A qualitative study
- (2020) Kristine H. Tillerås et al. Journal of Genetic Counseling
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
- (2020) Adam S. Fleisher et al. JAMA Neurology
- Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
- (2020) Antoine Leuzy et al. JAMA Neurology
- The C291R Tau Variant Forms Different Types of Protofibrils
- (2020) Thomas K. Karikari et al. Frontiers in Molecular Neuroscience
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- 18F-MK-6240 PET for early and late detection of neurofibrillary tangles
- (2020) Tharick A Pascoal et al. BRAIN
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Truncation of tau selectively facilitates its pathological activities
- (2020) Jianlan Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
- (2020) Antoinette O’Connor et al. MOLECULAR PSYCHIATRY
- Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
- (2020) Simon Dujardin et al. NATURE MEDICINE
- Blood Biomarkers: Democratizing Alzheimer’s Diagnostics
- (2020) Henrik Zetterberg et al. NEURON
- Addressing Health Disparities Among Minority Populations
- (2020) Consuelo H. Wilkins et al. JAMA Neurology
- Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study
- (2020) Kumar B. Rajan et al. ANNALS OF NEUROLOGY
- Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
- (2020) David Mengel et al. ANNALS OF NEUROLOGY
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid
- (2020) Gallen Triana-Baltzer et al. JOURNAL OF ALZHEIMERS DISEASE
- Predictive testing for neurodegenerative diseases in the age of next‐generation sequencing
- (2020) Jill Goldman et al. Journal of Genetic Counseling
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias
- (2020) Jozef Hanes et al. NEUROLOGY
- Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches
- (2020) Emily Hill et al. Frontiers in Molecular Neuroscience
- CSF phosphorylated tau‐217 is increased in Alzheimer’s and Creutzfeldt‐Jakob diseases and correlates with amyloid pathology
- (2020) Andreja Emeršič et al. Alzheimers & Dementia
- Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
- (2020) Thomas K. Karikari et al. Alzheimers & Dementia
- Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
- (2020) Alexis Moscoso et al. BRAIN
- CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
- (2020) Kanta Horie et al. BRAIN
- Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis
- (2020) Aiysha Chaudhry et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals
- (2020) Jasmeer P. Chhatwal et al. Nature Communications
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
- (2019) John C. Morris et al. JAMA Neurology
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort
- (2019) Sashika Selvackadunco et al. JOURNAL OF NEURAL TRANSMISSION
- Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
- (2019) Valeria Lifke et al. CLINICAL BIOCHEMISTRY
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Influx of Tau and Amyloid-β Proteins into the Blood During Hemodialysis as a Therapeutic Extracorporeal Blood Amyloid-β Removal System for Alzheimer’s Disease
- (2019) Nobuya Kitaguchi et al. JOURNAL OF ALZHEIMERS DISEASE
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Distinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains
- (2019) Thomas K. Karikari et al. Frontiers in Cellular Neuroscience
- Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
- (2019) Niklas Mattsson et al. JAMA Neurology
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
- (2019) Maria João Leitão et al. Alzheimers Research & Therapy
- Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
- (2019) Kaj Blennow et al. BRAIN
- Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2018) Thomas K. Karikari et al. Frontiers in Neurology
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
- (2018) Claudia Cicognola et al. ACTA NEUROPATHOLOGICA
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease
- (2018) Zhicheng Chen et al. Alzheimers & Dementia
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease
- (2017) Kacie D. Deters et al. JOURNAL OF ALZHEIMERS DISEASE
- Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
- (2017) Erik Portelius et al. Molecular Neurodegeneration
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
- (2017) Michelle M. Mielke et al. JAMA Neurology
- Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau–Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers
- (2017) Richard Rubenstein et al. JAMA Neurology
- Tau plasma levels in subjective cognitive decline: Results from the DELCODE study
- (2017) Stephan Müller et al. Scientific Reports
- Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects
- (2017) Aurélien Lathuilière et al. Scientific Reports
- Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline
- (2016) David J. Koss et al. ACTA NEUROPATHOLOGICA
- Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort
- (2016) Jeffrey L. Dage et al. Alzheimers & Dementia
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
- (2016) Shashank Shekhar et al. PLoS One
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- A Novel, Ultrasensitive Assay for Tau: Potential for Assessing Traumatic Brain Injury in Tissues and Biofluids
- (2015) Richard Rubenstein et al. JOURNAL OF NEUROTRAUMA
- Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice
- (2015) Alexandra J. Mably et al. NEUROBIOLOGY OF DISEASE
- Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment
- (2015) Anlys Olivera et al. JAMA Neurology
- A Practical Guide to Immunoassay Method Validation
- (2015) Ulf Andreasson et al. Frontiers in Neurology
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
- (2014) Zhentao Zhang et al. NATURE MEDICINE
- Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
- (2014) Pashtun Shahim et al. JAMA Neurology
- The global prevalence of dementia: A systematic review and metaanalysis
- (2013) Martin Prince et al. Alzheimers & Dementia
- Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma
- (2013) Sanna Neselius et al. BRAIN INJURY
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
- (2013) Jere E. Meredith Jr. et al. PLoS One
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
- (2013) Gaël Chételat et al. NeuroImage-Clinical
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The use of PET in Alzheimer disease
- (2010) Agneta Nordberg et al. Nature Reviews Neurology
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models
- (2009) Qipeng Zhang et al. ACTA NEUROPATHOLOGICA
- Accumulation of Aspartic Acid421- and Glutamic Acid391-Cleaved Tau in Neurofibrillary Tangles Correlates With Progression in Alzheimer Disease
- (2009) Gustavo Basurto-Islas et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Recruitment of minority and underserved populations in the United States: The centers for population health and health disparities experience
- (2008) Electra D. Paskett et al. Contemporary Clinical Trials
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started